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Abstract
Information on pneumococcal disease, including immunisation programs, and optimum future surveillance in each 
Australian State and Territory were discussed at the Pneumococcal Disease in Australia Workshop on 26-27 March 
1999. Workshop participants further expanded on the surveillance aspects of the Workshop in this re port. Most
participants favoured notification by laboratories of pneumococcal isolates from sterile sites, to provide baseline
surveillance data before immunisation programs are fully implemented. It was also thought that trends in
antimicrobial resistance should be notified. Commun Dis Intell 2000;24:93-95.
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The available data on pneumococcal disease differ widely
among jurisdictions in Australia. The situation was outlined
by participants from each State and Territory at the
Workshop. Workshop discussions about these data and
optimum future surveillance for pneumococcal disease in
Australia, have been expanded on and summarised below.
Data available in all jurisdictions
Hospital discharge data for ICD codes covering
pneumococcal disease are available in all States and
Territories. However, the system lacks timeliness, with a
12–18 month lag to the most recent completed data.
Mortality data from the Australian Bureau of Statistics have
similar limitations. The ICD code for pneumococcal
pneumonia in particular is non-specific, but potentially useful 
for monitoring trends. Neither data source gives information
about the serotype or antimicrobial susceptibility of
pneumococcal isolates.
Data available in some jurisdictions
Invasive pneumococcal disease is currently notifiable in the
Northern Territory (since 1994) and Queensland (since
1996). Some other jurisdictions have specific pneumococcal 
surveillance through voluntary laboratory networks
coordinated locally (Victoria, Western Australia,
metropolitan New South Wales). Thus only South Australia,
Tasmania and the Australian Capital Territory have no
current pneumococcal surveillance beyond hospital
discharge and mortality data. The available data sources by
State/Territory are shown in Table 1.
Pneumococcal immunisation programs
Indigenous populations
The three jurisdictions with the largest proportions of
Aboriginal and Torres Strait Islander residents (Northern
Territory, Queensland and Western Australia) all have
current or past pneumococcal immunisation programs for
some or all of their indigenous population. High rates of
invasive pneumococcal disease have been most completely 
documented for the longest period in Central Australia1  and
subsequently the rest of the Northern Territory. The
Northern Territory had an ‘adults are at risk’ campaign to
promote adult immunisation, including pneumococcal
immunisation, in 1994–95. Subsequently, project officers
were employed (1995–97) to promote and distribute free
pneumococcal vaccine to Aboriginal persons over 50 years
of age or with risk factors. From vaccine distribution data, it
was estimated that 50% of the target population was
immunised; this has probably decreased since funding of
project officers ceased. In Western Australia a number of
regional pneumococcal immunisation programs were
conducted in the north of the State from 1986, initially
targeting children aged 2–15 years (Pilbara and parts of
Kimberly) and more recently adults over 50 years of age.
The impact of these initiatives is being evaluated by Dr
Donna Mak from Kimberley Public Health Unit, but is
hampered by lack of documentation. In Far North
Queensland the Tropical Public Health Unit has
implemented both pneumococcal surveillance and
immunisation (personal communication, Jeffrey Hanna).
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Non-indigenous populations
Victoria is the only jurisdiction to make pneumococcal
vaccine available free of charge to non-indigenous adults
over 65 years of age. The Victorian program was
implemented in 1998, with an estimated increase in
coverage in the over-65 year old population of 30%, giving a
cumulative coverage of 42% by the end of 1998. The cost of
the program, with 199,000 doses distributed, was estimated
to be $5.74 million. Several other jurisdictions have
estimated (by telephone survey) pneumococcal vaccine
coverage in those over 65 years of age to be less than 10%.
Requirements for pneumococcal
surveillance
The data required for adequate surveillance of
pneumococcal disease relate to two main areas:
1. monitoring of antimicrobial resistance, with the aim of
providing feedback to influence antimicrobial prescribing;
and 
2. monitoring the impact of pneumococcal immunisation
programs, both for polysaccharide vaccines in at-risk adults
and for conjugate pneumococcal vaccines when these
become part of the routine schedule.
Requirements for surveillance were discussed at the
Workshop by three groups with broad representation. There
was general agreement that surveillance was necessary,
and that this should be based on laboratory reporting of
sterile site isolates. While recognising the differences
between jurisdictions in legal frameworks for notifiable
diseases, the majority thought that adequate surveillance
would be best achieved by making invasive pneumococcal
disease (defined by an isolate from a sterile site) notifiable.
The variables required would be similar to those in the
enhanced Hib Surveillance Scheme which requires, in
addition to basic demographic data, information about
Aboriginality, immunisation status and underlying
disease/risk factors of notified cases. Laboratory data are
required to determine the prevalence of resistance and
serotypes. The serotype of the isolate is especially
important information from immunised cases. Serotyping is
currently being performed in Western Australia (VISN),
Northern Territory (Menzies School), Queensland
(Queensland Health Scientific Services), New South Wales
(New Children’s Hospital/ICPMR) and Victoria (MDU).
Recommendations
Notification
The majority of workshop participants and State/Territory
representatives were in favour of pneumococcal isolates
from sterile sites being notifiable to State/Territory health
departments. Notification would be direct from the
laboratory and would be facilitated by the development of
electronic data transfer, as for other predominantly
laboratory-notified conditions. Concern was expressed that
introducing compulsory notification might adversely affect
existing voluntary laboratory notification schemes. The
public health action arising out of notifications would
primarily relate to monitoring of immunisation programs, and 
would provide an important baseline for evaluation before
immunisation programs are funded and fully implemented.
The public health action could also include promotion of
appropriate antibiotic use by monitoring trends in
antimicrobial resistance.
Data required for notification
The primary role of monitoring immunisation programs
means that Aboriginality, the presence of indications for
immunisation as defined by the National Health and Medical
Research Council (NHMRC), and immunisation status are
important variables for this notification system. This will
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Jurisdiction Data source
Notifications Laboratory network
Serotyping
Data available Performed locally
ACT No No No No
NSW No Yes1 Yes1 Yes
NT Yes Yes2 Yes2 No
Qld Yes No Yes3 Yes
SA No No Discontinued No
Tas No No No No
Vic No Yes4 Yes4 Yes
WA No Yes5 Yes5 Yes
Table 1. Sources of data for surveillance of pneumococcal disease, by jurisdiction
1. Metropolitan NSW Pneumococcal Study Group — voluntary.
2. Public microbiology laboratories refer isolates to Queensland Health Scientific Services.
3. Isolates forwarded by some laboratories only. Complete for Far North Queensland region.
4. Victorian Hospital Pathogen Surveillance Scheme — ongoing.
5. Vaccine Impact Surveillance Network — laboratory network funded by Health Department of Western Australia.
need to be determined in line with the current review of data
requirements for surveillance of vaccine preventable
diseases.
Laboratory support
The Public Health Laboratory Network was seen as the most 
appropriate group to oversee laboratory data for
pneumococcal disease. The high incidence of
pneumococcal disease, the different serotype distribution
and existing immunisation programs in Aboriginal compared 
with other populations, necessitates special attention to
serotyping of all available isolates from this group. For the
non-Aboriginal population, serotyping could be restricted to
a sample of isolates to monitor trends.
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Food policy in the National Centre for
Disease Control
In response to industry and consumer concerns relating to
many food issues, the Commonwealth Department of
Health and Aged Care recently formed a Food Policy
Section within the National Centre for Disease Control of the 
Population Health Division (PHD). Under the direction of
Dr Ian McKay, the Food Policy Section’s brief includes: 
• coordinating Commonwealth policy development in
relation to food, with a focus on food safety; 
• strengthening the evidence base for national and
Commonwealth decision-making on food policy issues; 
• fostering collaborative partnerships between
government, consumers and the food industry; and
• promoting nationally consistent approaches to food
policy regulation and action.
Food safety projects are a major part of the Food Policy
Section’s activities. These are to be conducted over the next 
two years with a funding allocation of $4.6 million over that
period. These activities will provide reliable data to help
industry introduce cost effective food safety management
systems and to initiate studies to better estimate the
incidence of, and reduce foodborne illness. As a starting
point for this work, a meeting of key stakeholders, the Food
Safety Forum, was held in mid-February. It is expected that
the Forum will be convened on a regular basis, and will act
as a consultative body.
The Forum was attended by representatives of
Commonwealth, State and Territory Governments, the
Australian and New Zealand Food Authority (ANZFA),
scientists and representatives of consumer and industry
groups. The projects comprising the two year program of
work were discussed, and their scope and aims generally
received support. Some of the intended projects are outlined 
below.
• A study examining the efficacy of food safety programs
will track the introduction of food safety programs into
food premises and subsequently observe food handling
practices. Industry and State Government
representatives have offered to collaborate on the
project. Following the debate at the Forum, the terms of
reference for the project have been broadened to include
costs and benefits of the introduction of food safety
programs, to businesses. A consultant will be
commissioned to undertake this work within the next few
months. 
• A project involving the establishment of sentinel sites in
rural and urban locations will collect data on foodborne
illness. This attracted strong support from Forum
participants. The activities will include establishing a
network of epidemiologists/data managers to analyse
outbreak data and issues related to better information
transfer. The project will build on the work of the Hunter
Public Health Unit, and provide robust evidence on the
incidence of foodborne illness in Australia. The
Commonwealth will fund each site for two years, in
interested jurisdictions. The funding would cover
employing an epidemiologist/data manager, travel,
laboratory tests, specimen equipment, courier charges
and interviewer fees. In making this offer, interested
jurisdictions would be expected to contribute resources
through provision of infrastructure requirements for the
site such as working space, operational facilities such as
computer, telephone and facsimile as well as support
services as required. The Commonwealth will employ a
project manager to coordinate the activities of the sites
and to act as a central liaison and coordination point.
Regular quarterly meetings between the epidemiologists
and State/Territory and Commonwealth agencies will
take place to ensure consistency of data collection and
collation. A meeting of interested State/Territories,
ANZFA and PHD was held in March to discuss the scope
and activities to be undertaken. Contract negotiations are 
currently underway with interested jurisdictions.
• A project to examine food contamination in Australia will
involve collaboration with ANZFA and State and Territory 
health authorities to implement new food surveillance
initiatives. This will contribute to State and Territory
initiatives of Senior Food Officers and ANZFA to put in
place a systematic and coordinated approach to food
surveillance.
Advertisements will appear in the national press shortly,
seeking submissions for consultancies related to some of
these projects. Future editions of CDI will include progress
reports.
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